[HTML][HTML] 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American …

DO Kleindorfer, A Towfighi, S Chaturvedi, KM Cockroft… - Stroke, 2021 - journals.lww.com
1. Specific recommendations for prevention strategies often depend on the ischemic
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …

Surgical management of moyamoya disease

G Acker, L Fekonja, P Vajkoczy - Stroke, 2018 - ahajournals.org
RCT. Here, the annual risk of secondary rehemorrhage in adults was significantly reduced
from 8% in the nonsurgical group to 3% in the STA-MCA bypass group. 11 Unfortunately, a …

2021 Japanese guidelines for the management of moyamoya disease: guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society

M Fujimura, T Tominaga, S Kuroda… - Neurologia medico …, 2022 - jstage.jst.go.jp
1Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo,
Hokkaido, Japan 2Department of Neurosurgery, Tohoku University Graduate School of …

European stroke organisation (ESO) guidelines on moyamoya angiopathy endorsed by vascular european reference network (VASCERN)

A Bersano, N Khan, B Fuentes, F Acerbi… - European Stroke …, 2023 - journals.sagepub.com
The European Stroke Organisation (ESO) guidelines on Moyamoya Angiopathy (MMA),
developed according to ESO standard operating procedure and Grading of …

Progression in moyamoya disease: clinical features, neuroimaging evaluation, and treatment

X Zhang, W **ao, Q Zhang, D **a, P Gao… - Current …, 2022 - benthamdirect.com
Moyamoya disease (MMD) is a chronic cerebrovascular disease characterized by
progressive stenosis of the arteries of the circle of Willis, with the formation of collateral …

[HTML][HTML] Direct versus indirect bypass procedure for the treatment of ischemic moyamoya disease: results of an individualized selection strategy

TH Nielsen, K Abhinav, ES Sussman, SS Han… - Journal of …, 2020 - thejns.org
OBJECTIVE The only effective treatment for ischemic moyamoya disease (iMMD) is cerebral
revascularization by an extracranial to intracranial bypass. The preferred revascularization …

Direct vs indirect revascularization in a North American cohort of moyamoya disease

PMR Lai, NJ Patel, KU Frerichs, AB Patel… - …, 2021 - journals.lww.com
BACKGROUND In adults with ischemic moyamoya disease (MMD), the efficacy of direct vs
indirect revascularization procedures remains a matter of debate. OBJECTIVE To investigate …

TGFβ1 as a predictive biomarker for collateral formation within ischemic moyamoya disease

Y Chen, M Tang, H Li, H Liu, J Wang… - Frontiers in …, 2022 - frontiersin.org
Objective Moyamoya disease (MMD) is a unique cerebrovascular occlusive disease
characterized by progressive steno-occlusion within the terminal segment of the internal …

Direct versus indirect revascularization for moyamoya: a large multicenter study

K El Naamani, CJ Chen, R Jabre, H Saad… - Journal of Neurology …, 2024 - jnnp.bmj.com
Background Moyamoya is a chronic occlusive cerebrovascular disease of unknown etiology
causing neovascularization of the lenticulostriate collaterals at the base of the brain …

Surgical treatment of adult moyamoya disease

SU Lee, CW Oh, OK Kwon, JS Bang, SP Ban… - … Treatment Options in …, 2018 - Springer
Purpose of review Moyamoya disease (MMD) is being increasingly diagnosed with the
development of radiological surveillance technology and increased accessibility to medical …